Targeted Therapeutics Research Award
Funded equally by LUNGevity Foundation and American Lung Association National Office
Patricia Gonzalez Santamaria, PhD
New York University School of Medicine
New York
NY
Dr. González Santamaria is investigating how the degradation of certain tumor suppressors (genes that stop cancer development) is accelerated and how that of certain onco-proteins (proteins that cause cancer) is slowed down in lung tumors. Her research will provide a platform for predicting the outcome for lung cancer patients.